News and events
Repurposed antiviral drugs – remdesivir, hydroxychloroquine, lopinavir and interferon – to treat COVID-19 appear to ...
Dr Christin Hoffmann is a Senior Research Associate in Health Services Research at the University ...
EVENT: Genomics and Healthcare – New Opportunities
30 November, 1.30pm – 2.30pm. Join the online Elizabeth Blackwell ...
Researchers contribute to international guidelines on exercise for people with cardiovascular disease
Work by two members of the NIHR Bristol BRC’s Cardiovascular ...
Using MRI heart scans to improve care for hospitalised COVID-19 patients
Researchers at the University of Bristol and University Hospitals Bristol ...
Good Grief: A virtual festival of love and loss
30 October – 1 November. NIHR Bristol BRC is supporting ...
Risk of self-harm increases for boys and girls who experience earlier puberty
Boys and girls who experience puberty earlier than their peers ...
“Involving patients and the public in research adds a different dynamic”
The NIHR Bristol BRC strategy group is made of eight public contributors. They meet with ...
Hundreds take part in study to support people with diabetes during COVID-19
More than 800 people have now taken part in our UK-wide online survey to identify ...
Switching to non-surgical approach to ankle fractures in older people could save £1.5 million a year
If half of patients aged 60 and over who had surgery for an ankle fracture ...
“Our patient advisory group has been invaluable”
The BRC’s Cardiovascular theme has been working with its patient advisory group (PAG) since 2017. ...
Genetic study of proteins is a breakthrough in drug development for complex diseases
An innovative genetic study of blood protein levels, led by researchers in the MRC Integrative ...
NIHR Bristol BRC contributing to ground-breaking national study into long-term health impacts of coronavirus
A major UK research study into the long-term health impacts of COVID-19 on hospitalised patients ...
Analysis of seven trials finds that corticosteroids reduce risk of death by 20 per cent in critically ill COVID-19 patients
Corticosteroids reduce the risk of death among critically ill COVID-19 patients by 20 per cent, ...